Revolve Biotechnologies, Inc. is a Baltimore-based company that specializes in the rapid discovery of optimal lead candidates from libraries of billions of variants. Their protein nucleic acid evolution platform allows for the construction of custom DNA variant libraries and high-affinity antibodies with industry-leading quality and turnaround time, making them the fastest and most economical option available on the market.
With a focus on high-affinity antibodies for diagnostic and therapeutic applications, oncolytic RNA cancer therapeutics, and infrared fluorescent proteins for live deep-tissue imaging, Revolve Biotechnologies offers comprehensive services for the construction of DNA variant libraries, industrial enzymes, and affinity binders. Their technology enables the exploration of vast sequence space that was previously inaccessible, providing customers with the results they need in a timely and efficient manner.
Generated from the website